Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported ZYME revenue for 2025-12-31 was $106.0M. Net income was -$81.1M. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. ZYME currently screens at market cap $1.68B.
Use this ZYME page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ZYME quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ZYME SEC filings page. Lician reads the product cache first so this HTML stays unique to Zymeworks Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full ZYME income, balance, and cash tables.